Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

Detalles Bibliográficos
Autores principales: Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184287/
http://dx.doi.org/10.1186/1546-0096-12-S1-P63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184287/
http://dx.doi.org/10.1186/1546-0096-12-S1-P63

Ejemplares similares